RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
RPTP was delisted on the 24th of October, 2016.
68 hedge funds and large institutions have $372M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 15 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 22
3% more call options, than puts
Call options by funds: $7.86M | Put options by funds: $7.63M
4% less funds holding
Funds holding: 71 → 68 (-3)
10% less capital invested
Capital invested by funds: $412M → $372M (-$39.3M)
20% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$39.6M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$10.1M |
| 3 |
Millennium Management
New York
|
+$6.59M |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$4.68M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$14.9M |
| 2 |
JP Morgan Chase
New York
|
-$9.65M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$6.48M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.64M |
| 5 |
Jane Street
New York
|
-$4.68M |
RPTP Hedge Fund Activity: Q4 2013 in Review
68 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q4 2013, worth a combined $372M — down 9.5% from $412M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of RPTP and 12 opened new positions — a net loss of 3 holders — while 22 trimmed existing stakes and 27 added.
The largest buyer was Goldman Sachs, adding an estimated $39.6M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $14.9M sold.
- 68 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q4 2013, down from 71 in Q3 2013.
- Funds reported $372M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q4 2013, down 9.5% quarter-over-quarter.
- 12 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q4 2013 and 15 closed out, a net change of -3 holders.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q4 2013 was Goldman Sachs, an estimated $39.6M added.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q4 2013 was Adage Capital Partners, an estimated $14.9M sold.
Based on aggregated 13F filings for Q4 2013.